Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-08-070634
Filing Date
2008-12-22
Accepted
2008-12-22 17:11:48
Documents
1
Period of Report
2008-12-22

Document Format Files

Seq Description Document Type Size
1 v135472_6k.htm 6-K 20209
  Complete submission text file 0001144204-08-070634.txt   21602
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 081264554
SIC: 2834 Pharmaceutical Preparations